ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $779,000 | +9.9% | 10,769 | 0.0% | 0.02% | -8.3% |
| Q4 2017 | $709,000 | -34.4% | 10,769 | -50.0% | 0.02% | +14.3% |
| Q3 2017 | $1,080,000 | -93.4% | 21,538 | -89.2% | 0.02% | -97.9% |
| Q2 2015 | $16,352,000 | +181588.9% | 200,000 | +195978.4% | 0.98% | +98400.0% |
| Q1 2015 | $9,000 | -99.9% | 102 | -100.0% | 0.00% | -99.9% |
| Q4 2014 | $12,233,000 | – | 302,500 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $99,609,000 | 22.32% |
| Bellevue Group AG | 5,465,715 | $203,160,000 | 2.81% |
| Rhenman & Partners Asset Management AB | 455,000 | $16,912,000 | 1.50% |
| Endurant Capital Management LP | 135,901 | $5,051,000 | 1.49% |
| Boxer Capital, LLC | 975,000 | $36,241,000 | 1.25% |
| DCF Advisers, LLC | 56,500 | $2,100,000 | 1.07% |
| Pentwater Capital Management LP | 2,169,022 | $80,623,000 | 1.04% |
| Nicholas Investment Partners, LP | 235,855 | $8,767,000 | 0.95% |
| Amia Capital LLP | 20,464 | $761,000 | 0.88% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,717,000 | 0.83% |